B
IRadimed Corporation IRMD
$69.57 -$1.12-1.58% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 11.73% 11.04% 11.71% 13.23% 16.05%
Total Other Revenue -- -- -- -- --
Total Revenue 11.73% 11.04% 11.71% 13.23% 16.05%
Cost of Revenue 12.94% 9.39% 9.66% 8.63% 11.48%
Gross Profit 11.38% 11.54% 12.34% 14.67% 17.47%
SG&A Expenses 12.70% 15.46% 15.71% 18.20% 15.76%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 12.04% 11.93% 12.63% 14.00% 12.99%
Operating Income 11.05% 9.01% 9.63% 11.47% 23.53%
Income Before Tax 10.31% 10.36% 11.67% 13.74% 26.97%
Income Tax Expenses 8.46% 10.27% 10.91% 12.45% 27.05%
Earnings from Continuing Operations 10.80% 10.39% 11.87% 14.09% 26.95%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 10.80% 10.39% 11.87% 14.09% 26.95%
EBIT 11.05% 9.01% 9.63% 11.47% 23.53%
EBITDA 10.52% 8.56% 9.53% 11.56% 21.45%
EPS Basic 10.27% 9.84% 11.28% 13.52% 26.40%
Normalized Basic EPS 9.74% 9.77% 11.03% 13.28% 26.54%
EPS Diluted 10.86% 9.82% 10.28% 12.85% 25.60%
Normalized Diluted EPS 9.68% 9.83% 11.16% 13.30% 26.32%
Average Basic Shares Outstanding 0.46% 0.50% 0.53% 0.50% 0.44%
Average Diluted Shares Outstanding 0.52% 0.44% 0.42% 0.50% 0.62%
Dividend Per Share 120.00% 326.67% 213.33% -- --
Payout Ratio -0.26% -0.11% -0.08% -0.22% -0.41%